(Hypertension. 1995;25:186-193.)
© 1995 American Heart Association, Inc.
Articles |
Role of Nitric Oxide in the Regulation of Coronary Vascular Tone in Hearts From Hypertensive Rats
Maintenance of Nitric Oxide–Forming Capacity and Increased Basal Production of Nitric Oxide
From the Department of Medicine, Division of Cardiology (M.K., T.K., W.M, B.E.S.), and Department of Physiology (A.D.), Heinrich-Heine Universität Düsseldorf, and the Department of Pharmacology, Schwarz Pharma AG Monheim (M.F.) (Germany).
Correspondence to Dr Malte Kelm, Department of Medicine, Division of Cardiology, Pneumology and Angiology, Heinrich-Heine-Universität, Moorenstraße 5, 40225 Düsseldorf, FRG.
Abstract In arterial hypertension, coronary flow reserve, expressed by the difference between autoregulated and maximal coronary flow, is frequently impaired. Previous experimental and clinical investigations using acetylcholine as a stimulus for the production of endothelium-derived relaxing factor suggested that an impaired endothelium-dependent vasodilation, presumably caused by a decreased formation of nitric oxide (NO), may account for this microvascular dysfunction. However, so far no study has been performed that quantifies the formation of NO within the coronary circulation of hypertensive hearts to assess its role in setting coronary vascular tone in the hypertensive heart. We therefore quantified NO formation within the coronary circulation of constant flow–perfused, isolated hearts from spontaneously hypertensive rats (SHR, 16th to 26th week), as a model for hypertensive heart disease, and from the normotensive control strain (Wistar-Kyoto, WKY) using the oxyhemoglobin technique. Coronary perfusion pressure and vascular resistance were almost 30% higher in SHR compared with WKY hearts. Intracoronarily applied NO decreased coronary vascular resistance by maximally 45% of resting values in a concentration-dependent manner in both groups. The bradykinin-induced decrease in coronary vascular resistance and the parallel increase in NO release were comparable in SHR and WKY hearts and fell within the vasodilator range of exogenously applied NO. Moreover, basal release of NO normalized to heart wet weight was 50% higher in SHR compared with WKY hearts. Rates of basal NO release were correlated inversely with changes in coronary perfusion pressure and vascular resistance in both groups (r=-.85 and -.84, respectively, P<.05). This relation between resting coronary vascular resistance and NO formation, as a critical determinant of coronary flow, was shifted significantly to higher levels in SHR. From the present data we conclude that in the coronary circulation of SHR, NO formation is preserved under basal and stimulated conditions and critically determines resting coronary resistance. Moreover, the enhanced basal release of NO may serve the purpose of compensating the higher coronary vascular resistance of hypertensive hearts.
Key Words: endothelium-derived relaxing factor • nitric oxide • hypertension, arterial • coronary circulation • bradykinin
This article has been cited by other articles:
 |
|
 |
|
  X. Zhou, H. G. Bohlen, S. J. Miller, and J. L. Unthank NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1008 - H1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Shipley and J. M. Muller-Delp Aging decreases vasoconstrictor responses of coronary resistance arterioles through endothelium-dependent mechanisms Cardiovasc Res, May 1, 2005; 66(2): 374 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Su, Q. Zhang, J. Moalem, J. Tse, P. M. Scholz, and H. R. Weiss Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1367 - H1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Kreutzer and T. Jue Role of myoglobin as a scavenger of cellular NO in myocardium Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H985 - H991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelm Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H1 - H5. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-H. Lee, T.-H. Hwang, G. T. Oh, S. U. Kwon, Y.-H. Choi, and J.-E. Park Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males Vascular Medicine, May 1, 2001; 6(2): 103 - 108. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Barton, L. V. d'Uscio, Y. Hirata, M. Kakoki, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, et al. Hypertension, Diabetes Mellitus, Hypercholesterolemia, and Endothelin B Receptor-Mediated Renal Nitric Oxide Release Response Circulation, June 13, 2000; 101 (23): e228 - e229. [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Liao, T. W. Hein, M. W. Vaughn, K.-T. Huang, and L. Kuo Intravascular flow decreases erythrocyte consumption of nitric oxide PNAS, July 20, 1999; 96(15): 8757 - 8761. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Y. Qiu, D. Henrion, J. Benessiano, C. Heymes, B. Tournier, and B. I. Levy Decreased Flow-Induced Dilation and Increased Production of cGMP in Spontaneously Hypertensive Rats Hypertension, December 1, 1998; 32(6): 1098 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Radaelli, L. Mircoli, I. Mori, G. Mancia, and A. U. Ferrari Nitric Oxide–Dependent Vasodilation in Young Spontaneously Hypertensive Rats Hypertension, October 1, 1998; 32(4): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bauersachs, A. Bouloumie, A. Mulsch, G. Wiemer, I. Fleming, and R. Busse Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production Cardiovasc Res, March 1, 1998; 37(3): 772 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelm, S. Schafer, R. Dahmann, B. Dolu, S. Perings, U. K.M Decking, J. Schrader, and B. E Strauer Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation Cardiovasc Res, November 1, 1997; 36(2): 184 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bouloumie, J. Bauersachs, W. Linz, B. A. Scholkens, G. Wiemer, I. Fleming, and R. Busse Endothelial Dysfunction Coincides With an Enhanced Nitric Oxide Synthase Expression and Superoxide Anion Production Hypertension, October 1, 1997; 30(4): 934 - 941. [Abstract] [Full Text]
|
|
|
|
 |
|
 C D A Goonasekera, V Shah, D D Rees, and M J Dillon Nitric oxide activity in childhood hypertension Arch. Dis. Child., July 1, 1997; 77(1): 11 - 16. [Abstract] [Full Text]
|
|
|
|
|
|
N. Ito, J. Bartunek, K. W. Spitzer, and B. H. Lorell Effects of the Nitric Oxide Donor Sodium Nitroprusside on Intracellular pH and Contraction in Hypertrophied Myocytes Circulation, May 6, 1997; 95(9): 2303 - 2311. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Biol. Chem., April 11, 1997; 272(15): 9922 - 9932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hayakawa and L. Raij The Link Among Nitric Oxide Synthase Activity, Endothelial Function, and Aortic and Ventricular Hypertrophy in Hypertension Hypertension, January 1, 1997; 29(1): 235 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Matsuoka, S. Itoh, M. Kimoto, K. Kohno, O. Tamai, Y. Wada, H. Yasukawa, G. Iwami, S. Okuda, and T. Imaizumi Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental Hypertension Hypertension, January 1, 1997; 29(1): 242 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nunez, K. Hosoya, D. Susic, and E. D. Frohlich Enalapril and Losartan Reduced Cardiac Mass and Improved Coronary Hemodynamics in SHR Hypertension, January 1, 1997; 29(1): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kelm, M. Preik, D. J. Hafner, and B. E. Strauer Evidence for a Multifactorial Process Involved in the Impaired Flow Response to Nitric Oxide in Hypertensive Patients With Endothelial Dysfunction Hypertension, March 1, 1996; 27(3): 346 - 353. [Abstract] [Full Text]
|
|